...
首页> 外文期刊>Medical care >Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine
【24h】

Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine

机译:经济模型透明度可以提高提供者对成本效益分析的解释吗? 评估第二小组在健康和医学成本效益上提出的权衡

获取原文
获取原文并翻译 | 示例
           

摘要

The Second Panel on Cost-Effectiveness in Health and Medicine convened on December 7, 2016 at the National Academy of Medicine to disseminate their recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses (CEAs). Following its summary, panel proceedings included lengthy discussions including the field's struggle to disseminate findings efficiently through peer-reviewed literature to target audiences. With editors of several medical and outcomes research journals in attendance, there was consensus that findings of cost-effectiveness analyses do not effectively reach other researchers or health care providers. The audience members suggested several solutions including providing additional training to clinicians in cost-effectiveness research and requiring that cost-effectiveness models are made publicly available. However, there remains the questions of whether making economic modelers' work open-access through journals is fair under the defense that these models remain one's own intellectual property, or whether journals can properly manage the peer-review process specifically for cost-effectiveness analyses. In this article, we elaborate on these issues and provide some suggested solutions that may increase the dissemination and application of cost-effectiveness literature to reach its intended audiences and ultimately benefit the patient. Ultimately, it is our combined view as economic modelers and clinicians that cost-effectiveness results need to reach the clinician to improve the efficiency of medical practice, but that open-access models do not improve clinician access or interpretation of the economics of medicine.
机译:第二届健康和医学成本效益小组于2016年12月7日在国家医学院召开,以传播其进行行为,方法实践和报告成本效益分析(CEA)的建议。在其摘要之后,小组诉讼包括冗长的讨论,包括该领域的斗争,以通过对同行评审的文献来传播调查结果来定位受众。借助若干医疗和成果的编辑出席,曾达成共识,即成本效益分析的结果没有有效地联系其他研究人员或医疗保健提供者。观众成员建议了几种解决方案,包括向临床医生提供额外的培训,以成本效益研究,要求公开可用成本效益模型。然而,仍然存在关于通过期刊进行经济建模者的工作开放式访问的问题是在国防方面的公平,这些模型仍然是自己的知识产权,或期刊是否可以专门针对成本效益分析来妥善管理同期审查流程。在本文中,我们详细阐述了这些问题,并提供了一些建议的解决方案,可能会增加成本效益文学的传播和应用,以达到其预定的受众,并最终使患者受益。最终,我们的综合观点是经济建设者和临床医生,成本效益结果需要到达临床医生以提高医疗实践的效率,但开放式车型不会改善临床医生的访问或对医学经济学的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号